Clinical Trial Update: DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating DCE-MRI with Dotarem® to assess therapeutic response to sorafenib in advanced hepatocellular carcinoma; study terminated with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• DOTAREM (Gadoterate meglumine)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Guerbet | Conditions: Hepatocellular Carcinoma | Phase 4 | Status: TERMINATED | Results posted: 2019-08-08